Validation Accelerates Adoption

The most likely path is that the papers hold up under early scrutiny and are treated as evidence that Meta's open AI stack can materially speed biomedical research. The market reaction remains company- and sector-specific because this is a research-productivity signal, not a macro event.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.